Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antitrypsin Deficiency Assessment and Programme for Treatment (ADAPT): The United Kingdom Registry.

COPD - 1 May 2015

Stockley Robert A

Abstract excerpt

The study of rare diseases is compromised by its rarity. The establishment of national and international registries can overcome many of the problems and be used for many monogenetic conditions with relatively consistent outcomes and thus lead to a consistency of clinical management by centres of excellence. However, in Alpha-1 antitrypsin deficiency (AATD), the outcome is highly variable in terms of the organ(s)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to alpha 1-Antitrypsin Deficiency

Share to Disease Progression

Share to Registries

Share to United Kingdom

Share to Young Adult

Source

Identifiers

PMID: 25938295
DOI: 10.3109/15412555.2015.1021911

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antitrypsin Deficiency Assessment and Programme for Treatment (ADAPT): The United Kingdom Registry.PMID 25938295Read ↗

Alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Phenotypes and Quality of Life.Semantic proximity Read ↗

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiencySemantic proximity Read ↗

Alpha-1-antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Role of alpha-1 antitrypsin in human health and disease.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicineSemantic proximity Read ↗

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiencySemantic proximity Read ↗

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development.Semantic proximity Read ↗

Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlookSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.